PTPRG suppresses tumor growth and invasion via inhibition of Akt signaling in nasopharyngeal carcinoma.
about
CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinomaGlutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS.Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma.DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.EGF-dependent re-routing of vesicular recycling switches spontaneous phosphorylation suppression to EGFR signaling.IL-17A promotes the proliferation of human nasopharyngeal carcinoma cells through p300-mediated Akt1 acetylation.Neural progenitor fate decision defects, cortical hypoplasia and behavioral impairment in Celsr1-deficient mice.The phosphatase PTPRG controls FGFR1 activity and influences sensitivity to FGFR kinase inhibitors.Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK ActivationIdentification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer riskInhibiting eEF-2 kinase-mediated autophagy enhanced the cytocidal effect of AKT inhibitor on human nasopharyngeal carcinomaInterdependence between EGFR and Phosphatases Spatially Established by Vesicular Dynamics Generates a Growth Factor Sensing and Responding NetworkGene expression profile of human lung in a relatively early stage of COPD with emphysema
P2860
Q36413308-16B38900-AD10-46EF-A94F-F1ED24BA5B20Q36742929-A34A494B-5723-4662-8413-FB46BFAFE2ECQ37392894-49B7DAB3-7958-4255-913D-0E328904F250Q37694718-A81C89E6-5A32-4EC1-A02E-F7029672FB40Q38743845-5007CC76-BEE6-4ADF-9B2B-E34BB9290F6EQ38816457-A8F7311B-6815-4CAA-B925-1F1AC4EC9E4DQ41899539-F0D944A6-64C1-410D-B4E0-1027BEDD5324Q47276678-69430326-79D5-4132-9A12-3E391C0F55ECQ47711378-D3D93688-E2D3-43C4-9163-F455F4C4EB6AQ56761471-D95DF56D-BB85-4669-BFE9-C1517C2EEA39Q58351997-C5F232DC-5360-4AFE-841B-EF7148EC70ABQ58694370-63AD49BA-9CB5-4849-83C2-147B8755BD37Q58694516-990FD53B-DCE9-43BD-9FF8-CD9D2E23D875Q58698660-C1A23CC8-2A88-4BFC-A6B0-D743402EA4CF
P2860
PTPRG suppresses tumor growth and invasion via inhibition of Akt signaling in nasopharyngeal carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
PTPRG suppresses tumor growth ...... g in nasopharyngeal carcinoma.
@ast
PTPRG suppresses tumor growth ...... g in nasopharyngeal carcinoma.
@en
type
label
PTPRG suppresses tumor growth ...... g in nasopharyngeal carcinoma.
@ast
PTPRG suppresses tumor growth ...... g in nasopharyngeal carcinoma.
@en
prefLabel
PTPRG suppresses tumor growth ...... g in nasopharyngeal carcinoma.
@ast
PTPRG suppresses tumor growth ...... g in nasopharyngeal carcinoma.
@en
P2093
P2860
P356
P1433
P1476
PTPRG suppresses tumor growth ...... ng in nasopharyngeal carcinoma
@en
P2093
Adrian Chi Hang Chu
Arthur Kwok Leung Cheung
Hong Lok Lung
Joseph Chok Yan Ip
Maria Li Lung
Merrin Man Long Leong
Wai Ho Shuen
P2860
P304
13434-13447
P356
10.18632/ONCOTARGET.3876
P407
P50
P577
2015-05-01T00:00:00Z